Pharmacokinetics of methylphenidate in man, rat and monkey.
The pharmacokinetics and bioavailability of methylphenidate (MPH) and a metabolite, ritalinic acid (RA), were studied in normal adults, children with hyperactivity, monkeys and rats. Adult males received 0.15 or 0.3 mg/kg of MPH orally and MPH and RA were analyzed in plasma samples obtained at various times after treatment. Maximal MPH concentrations in plasma were found to occur 2.2 hr after administration of either dose (range: 1.0-4.0). The mean (+/-S.E.) maximal concentration in plasma for MPH was 3.5 +/- 0.4 ng/ml after 0.15 mg/kg and 7.8 +/- 0.8 ng/ml after 0.3 mg/kg. MPH clearances were high (10.1 liters/hr/kg) and variable (range: 3.6-23.2) for the 0.3 mg/kg dose. Pharmacokinetic parameters for children receiving 0.3 mg/kg were essentially the same as for adults. RA plasma levels were 50 to 100 times greater than MPH levels in normal adults. The clearance of RA is less than that of MPH. The absolute bioavailability of MPH was found to be 0.19 in the rat and 0.22 in the monkey, suggesting substantial presystemic elimination of MPH.
D000328:Adult; D000818:Animals; D002648:Child; D000882:Haplorhini; D006801:Humans; D006948:Hyperkinesis / Q000097:blood; D007700:Kinetics; D008297:Male; D008774:Methylphenidate / Q000031:analogs & derivatives / Q000097:blood*; D051381:Rats; D013045:Species Specificity; D013997:Time Factors
D008774:Methylphenidate; C009189:ritalinic acid